Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer. Clinics, [S. l.], v. 73, n. Suppl. 1, p. e479s, 2019. DOI: 10.6061/clinics/2018/e479s. Disponível em: https://revistas.usp.br/clinics/article/view/154791.. Acesso em: 2 may. 2024.